Product Information
LAMOTRIGINE ODT 100 MG TABLET is a generic product labeled by Endo USA Inc., priced at $1.6250 per EA under NDC 49884048611. Its NADAC has been published 553 times since Mar 2, 2016.
FDA first approved this application on Oct 27, 2015. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the Lamotrigine market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
100 mg/1
Manufacturer
Endo USA Inc.NDC
49884048611
Classification
Generic
Dosage Form
TABLET, ORALLY DISINTEGRATING
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
LAMOTRIGINEApproval Type
Generic (ANDA)
FDA Application
ANDA204158FDA Approved
10/27/2015
TE Code
AB
On Market Since
12/16/2015
Pharmacological Classes
Price Statistics
The NADAC for LAMOTRIGINE ODT 100 MG TABLET has been published 553 times since Mar 2, 2016, and over the history we have for it it has declined 75.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.6250 per EA |
|---|---|
| All-time high | $7.2985 (May 11, 2016) |
| All-time low | $1.5108 (Aug 21, 2024) |
| 52-week high | $2.4101 |
| 52-week low | $1.6250 |
| Median price | $5.0086 |
| Average price | $4.5756 |
| Largest weekly change | +75.4% (Aug 23, 2023) |
| Weeks tracked | 553 |
| Tracking since | Mar 2, 2016 |
Generic Alternatives
The matcher finds 17 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 97% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Endo USA Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Lamotrigine market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Anti-epileptic Agent class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of LAMOTRIGINE ODT 100 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for LAMOTRIGINE ODT 100 MG TABLET, manufactured by Endo USA Inc., is $1.6250 per EA (NDC 49884048611), effective Sep 30, 2026.
How has the price of LAMOTRIGINE ODT 100 MG TABLET changed over time?
Over the history we have for it, the NADAC for LAMOTRIGINE ODT 100 MG TABLET has declined 75.4%. It has been tracked across 553 weekly CMS publications since Mar 2, 2016.
What are the highest and lowest recorded NADAC prices for LAMOTRIGINE ODT 100 MG TABLET?
Since Mar 2, 2016, the NADAC for LAMOTRIGINE ODT 100 MG TABLET has ranged from a low of $1.5108 (Aug 21, 2024) to a high of $7.2985 (May 11, 2016), with a median of $5.0086 per EA.
Are there cheaper alternatives to LAMOTRIGINE ODT 100 MG TABLET?
Yes. 17 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, LAMOTRIGINE 100 MG TABLET, is $0.0487 per EA — about 97% below LAMOTRIGINE ODT 100 MG TABLET.
Who manufactures LAMOTRIGINE ODT 100 MG TABLET?
LAMOTRIGINE ODT 100 MG TABLET (NDC 49884048611) is labeled by Endo USA Inc., and CMS classifies it as a generic product.